These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6814340)

  • 1. Chlorpropamide and glibenclamide serum concentrations in hospitalized patients.
    Huupponen R; Viikari J; Saarimaa H
    Ann Clin Res; 1982 Jun; 14(3):119-22. PubMed ID: 6814340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of glibenclamide & chlorpropamide in newly diagnosed maturity onset diabetics.
    Haider Z; Obaidullah S; Fayyaz-ud-Din
    J Pak Med Assoc; 1976 Feb; 26(2):23-6. PubMed ID: 817043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acute and prolonged effects of glibenclamide and chlorpropamide in patients with non-insulin-dependent diabetes.
    Ylitalo P; Oksala H; Pitkäjärvi T
    Arzneimittelforschung; 1985; 35(10):1596-9. PubMed ID: 3935120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between serum concentration and hypoglycemic effect of chlorpropamide in man.
    Jankowski A; Wichliński LM; Bokowski W; Romański B
    Pol J Pharmacol Pharm; 1984; 36(5):449-53. PubMed ID: 6533629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glibenclamide--a better antidiabetic agent?].
    Blohmé G
    Lakartidningen; 1972 Dec; 69(52):6147-9. PubMed ID: 4631025
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of chlorpropamide and glibenclamide treatment of maturity-onset diabetes: control assessed by fasting plasma glucose concentrations.
    Ward EA; Lang DA; Phillips MR; Turner RC
    Diabetes Care; 1981; 4(2):293-5. PubMed ID: 6783374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reaction of diabetic carbohydrate metabolism on the change from chlorpropamide to glibenclamide].
    Henning H; Look D
    Dtsch Med J; 1972 Oct; 23(10):634-6. PubMed ID: 4630502
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glibenclamide and diabetes mellitus. 1. Year's clinical experience].
    Contreras AR; Gabrielli S; Baigorria L
    Prensa Med Argent; 1972 May; 59(15):581-3. PubMed ID: 4626172
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Diabetologia; 1980 Jan; 18(1):17-22. PubMed ID: 6767639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.
    Sönksen PH; Lowy C; Perkins JR; West TE
    Diabetologia; 1981; 20(1):22-30. PubMed ID: 6781962
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum digoxin concentration: dependence on body weight and age].
    Kaufmann G; Neumann P
    Schweiz Med Wochenschr; 1977 Nov; 107(47):1695-9. PubMed ID: 929130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical testing of a sulfonylurea preparation (glibenclamide)].
    Sigroth K; Steen B; Svanborg A
    Lakartidningen; 1969 Nov; 66(45):4647-50. PubMed ID: 4996889
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus.
    Melander A; Sartor G; Wåhlin E; Scherstén B; Bitzén PO
    Br Med J; 1978 Jan; 1(6106):142-4. PubMed ID: 620227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of glibenclamide and chlorpropamide. (Preliminary report).
    Hamblin JJ; Ismay G; Good MS; Wynne-Williams CJ; Baum G; Wilson IV
    Postgrad Med J; 1970 Dec; ():Suppl:92-4. PubMed ID: 5533305
    [No Abstract]   [Full Text] [Related]  

  • 16. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE; Calderara A; Pacchioni M; Cassisa C; Pozza G
    Diabete Metab; 1993; 19(1):30-5. PubMed ID: 8504882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma insulin, C-peptide and glucagon concentrations in patients with insulin-independent diabetes treated with chlorpropamide.
    Frier BM; Ashby JP; Nairn IM; Baird JD
    Diabete Metab; 1981 Mar; 7(1):45-9. PubMed ID: 7016620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term comparative trial of glibenclamide and chlorpropamide in diet-failed, maturity-onset diabetics.
    Clarke BF; Campbell IW
    Lancet; 1975 Feb; 1(7901):246-8. PubMed ID: 8667857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of glibenclamide, chlorpropamide and tolbutamide in plasma by high-performance liquid chromatography with ultraviolet detection.
    Zecca L; Trivulzio S; Pinelli A; Colombo R; Tofanetti O
    J Chromatogr; 1985 Apr; 339(1):203-9. PubMed ID: 3926803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.